Basilea Pharmaceutica

This study is testing whether a new medication called fosmanogepix works as well as current standard treatments for serious Candida fungal infections in the blood or organs. About 450 adults with these life-threatening infections will receive either the new treatment or standard …

This study is testing a new drug called fosmanogepix for adults with severe, invasive mold infections that are often resistant to other treatments. It will compare the new drug to standard antifungal care for some patients and use it as a rescue therapy for others who haven't res…

This is an early safety study for a new combination antibiotic pill. Researchers will give the drug to about 46 healthy adults to see how safe it is and to measure how the body absorbs and processes it. The main goal is to understand the drug's behavior in the body and identify a…

This is the first study in people for a new antibiotic called BAL2420, which is being developed to fight serious bacterial infections. Researchers are testing it in healthy volunteers to see if it is safe, how well it is tolerated, and how the body processes it. The study will gi…